Literature DB >> 25996905

Cirrhotic liver: What's that nodule? The LI-RADS approach.

Amol Shah1, An Tang1,2, Cynthia Santillan1, Claude Sirlin1.   

Abstract

The Liver Imaging Reporting and Data System (LI-RADS) is an American College of Radiology (ACR)-endorsed diagnostic system of standardized terminology, interpretation, and reporting for imaging examinations of the liver in patients at high risk for hepatocellular carcinoma (HCC). LI-RADS assigns a category to observations in the liver indicating the likelihood of benignity or HCC. LI-RADS categories include LR-1: Definitely Benign, LR-2: Probably Benign, LR-3: Intermediate Probability for HCC, LR-4: Probably HCC, LR-5: Definite HCC, LR-5V: Definite HCC with Tumor in Vein, LR-Treated: Treated HCC, LR-M Probable Malignancy, not specific for HCC. This article reviews the types of nodules seen in the cirrhotic liver, examines core LI-RADS concepts and definitions, and utilizes the LI-RADS v2014 algorithm to categorize representative observations depicted at magnetic resonance imaging in a case-based approach.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ACR; HCC; LI-RADS

Mesh:

Year:  2015        PMID: 25996905     DOI: 10.1002/jmri.24937

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  12 in total

1.  Hepatic Lesions in a Cirrhotic Liver: Primary or Metastases?

Authors:  Lorenzo Mannelli; Serena Monti; Verena Grieco; Manuela Matesan
Journal:  J Nucl Med Technol       Date:  2017-02-02

2.  Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.

Authors:  Sun Kyung Jeon; Ijin Joo; Dong Ho Lee; Sang Min Lee; Hyo-Jin Kang; Kyoung-Bun Lee; Jeong Min Lee
Journal:  Eur Radiol       Date:  2018-06-28       Impact factor: 5.315

3.  Use of the Liver Imaging Reporting and Data System in Hepatocellular Carcinoma.

Authors:  Claude Sirlin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-06

4.  Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.

Authors:  Dong Ik Cha; Kyung Mi Jang; Seong Hyun Kim; Tae Wook Kang; Kyoung Doo Song
Journal:  Eur Radiol       Date:  2017-04-03       Impact factor: 5.315

5.  Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI?

Authors:  Sidong Xie; Yao Zhang; Jingbiao Chen; Ting Jiang; Weimin Liu; Dailin Rong; Lin Sun; Linqi Zhang; Bingjun He; Jin Wang
Journal:  Abdom Radiol (NY)       Date:  2021-11-13

Review 6.  Imaging of HCC-Current State of the Art.

Authors:  Christina Schraml; Sascha Kaufmann; Hansjoerg Rempp; Roland Syha; Dominik Ketelsen; Mike Notohamiprodjo; Konstantin Nikolaou
Journal:  Diagnostics (Basel)       Date:  2015-11-27

Review 7.  Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.

Authors: 
Journal:  Korean J Radiol       Date:  2017-04-03       Impact factor: 3.500

8.  Digital subtract angiography and lipiodol deposits following embolization in cirrhotic nodules of LIRADS category ≥3.

Authors:  Zhen Kang; Nan Wang; Anhui Xu; Liang Wang
Journal:  Eur J Radiol Open       Date:  2019-02-23

Review 9.  LI-RADS v2017 for liver nodules: how we read and report.

Authors:  Wolfgang Schima; Jay Heiken
Journal:  Cancer Imaging       Date:  2018-04-24       Impact factor: 3.909

Review 10.  State of the art in abdominal MRI structured reporting: a review.

Authors:  Arnaldo Stanzione; Francesca Boccadifuoco; Renato Cuocolo; Valeria Romeo; Pier Paolo Mainenti; Arturo Brunetti; Simone Maurea
Journal:  Abdom Radiol (NY)       Date:  2020-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.